Chemoinformaics analysis of TRICIN-7-O-BETA-D-GLUCOSIDE
| Molecular Weight | 492.433 | nRot | 6 |
| Heavy Atom Molecular Weight | 468.241 | nRig | 24 |
| Exact Molecular Weight | 492.127 | nRing | 4 |
| Solubility: LogS | -3.708 | nHRing | 2 |
| Solubility: LogP | 0.873 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 2 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 17 |
| nHA | 12 | APOL | 64.037 |
| nHD | 6 | BPOL | 33.625 |
| QED | 0.272 |
| Synth | 3.958 |
| Natural Product Likeliness | 1.812 |
| NR-PPAR-gamma | 0.955 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.009 |
| Pgp-sub | 0.982 |
| HIA | 0.877 |
| CACO-2 | -6.086 |
| MDCK | 0.0000508 |
| BBB | 0.129 |
| PPB | 0.727774 |
| VDSS | 0.989 |
| FU | 0.243492 |
| CYP1A2-inh | 0.033 |
| CYP1A2-sub | 0.481 |
| CYP2c19-inh | 0.013 |
| CYP2c19-sub | 0.131 |
| CYP2c9-inh | 0.006 |
| CYP2c9-sub | 0.362 |
| CYP2d6-inh | 0.022 |
| CYP2d6-sub | 0.297 |
| CYP3a4-inh | 0.032 |
| CYP3a4-sub | 0.032 |
| CL | 3.825 |
| T12 | 0.641 |
| hERG | 0.058 |
| Ames | 0.609 |
| ROA | 0.021 |
| SkinSen | 0.123 |
| Carcinogencity | 0.076 |
| EI | 0.01 |
| Respiratory | 0.072 |
| NR-Aromatase | 0.871 |
| Antiviral | Yes |
| Prediction | 0.887564 |